Patents by Inventor Bernhard Günther

Bernhard Günther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID PHARMACEUTICAL COMPOSITION FOR THE DELIVERY OF ACTIVE INGREDIENTS
    Publication number: 20130266652
    Abstract: The invention provides novel pharmaceutical compositions based on semifluorinated alkanes which are useful as carriers for a broad range of active ingredients. Preferred active ingredients include poorly water-soluble and/or hydrolytically sensitive drug substances. The compositions are designed as suspensions and have superior physical properties which make them highly useful as pharmaceutical delivery systems. The compositions may be administered topically into the eye, or injected via the subcutaneous or intramuscular route. The invention further provides kits comprising such compositions.
    Type: Application
    Filed: October 18, 2011
    Publication date: October 10, 2013
    Applicant: Novaliq GmbH
    Inventors: Bastian Theisinger, Sonja Theisinger, Bernhard Günther
  • COMPOSITIONS AND METHODS FOR IMPROVED ORGAN TRANSPLANT PRESERVATION AND ACCEPTANCE
    Publication number: 20130142866
    Abstract: The invention provides a novel aqueous composition for the storage and preservation of transplants, such as organ or tissue allografts. The composition comprises the compound N-octanoyl dopamine in solubilised form. The composition may also be administered as a pre-treatment of transplant donors. Moreover, it may be used in transplant recipients, optionally in combination with immunosuppressants.
    Type: Application
    Filed: August 16, 2011
    Publication date: June 6, 2013
    Applicant: NOVALIQ GMBH
    Inventors: Bastian Theisinger, Sonja Theisinger, Bernhard Günther
  • PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DRY EYE SYNDROME
    Publication number: 20120244177
    Abstract: The invention provides novel pharmaceutical compositions for the treatment of keratoconjunctivitis sicca comprising liquid vehicles which include one or more semifluorinated alkanes. The compositions incorporate an active ingredient selected from the group of macrolide immunosuppressants. They can be administered topically into the eye. The invention further provides kits comprising such compositions.
    Type: Application
    Filed: December 13, 2010
    Publication date: September 27, 2012
    Applicant: NOVALIQ GMBH
    Inventors: Bastian Theisinger, Sonja Theisinger, Bernhard Günther
  • Method for preserving organs or limbs using a composition containing a siloxane and a semifluorinated alkane and/or hydrofluoroether
    Patent number: 8029977
    Abstract: Use of a composition which contains at least one semifluorinated alkane compound and at least one liquid siloxane, wherein the composition is of a density in a range of 0.8 to 1.5 g/cm3, for preserving organs or limbs.
    Type: Grant
    Filed: November 23, 2006
    Date of Patent: October 4, 2011
    Assignee: NOVALIQ GmbH
    Inventors: Hasso Meinert, Bernhard Günther, Wilfried Hiebl, Bastian Mühling, Daniel Brandhorst
  • USE OF A COMPOSITION FOR PRESERVING ORGANS AND MEMBERS
    Publication number: 20090226875
    Abstract: Use of a composition which contains at least one semifluorinated alkane compound and at least one liquid siloxane, wherein the composition is of a density in a range of 0.8 to 1.5 g/cm3, for preserving organs or limbs.
    Type: Application
    Filed: November 23, 2006
    Publication date: September 10, 2009
    Applicant: Novaliq GmbH
    Inventors: Hasso Meinert, Bernhard Günther, Wilfried Hiebl, Bastian Mühling, Daniel Brandhorst